COVID-19 Treatment Resistance
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?

Released: January 04, 2023

Expiration: January 03, 2024

Fernando Carnavali
Fernando Carnavali, MD
Rasika Karnik
Rasika Karnik, MS, MD
Renslow Sherer
Renslow Sherer, MD
Joseph Torrisi
Joseph Torrisi, PharmD, BCIDP

Activity

Progress
1
Course Completed

Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 treatments and the possibility for antiviral resistance, including:

  • Treatment resistance mechanisms
  • COVID-19 testing
  • COVID-19 treatments, including antivirals and monoclonal antibodies